You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 250 No. 6, August 12, 1983 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Long-term diazepam therapy and clinical outcome

K. Rickels, W. G. Case, R. W. Downing and A. Winokur

This double-blind study involved the continuous (six to 22 weeks) treatment of 180 chronically anxious outpatients with diazepam, 15 to 40 mg/day. Our findings indicate that a significant number of patients benefit from prolonged diazepam treatment and that tolerance to the anxiolytic effect of diazepam does not develop during a 22-week study period. The duration of continual treatment with sedative-benzodiazepines was clearly the most important determinant of withdrawal reactions. Patients treated continuously for less than eight months with sedative-benzodiazepines had an incidence of withdrawal of 5%, whereas 43% of patients treated for eight months or more demonstrated clear withdrawal reactions. While these withdrawal reactions produced considerable distress, they were neither life threatening nor incapacitating and did not include convulsions or psychotic reactions. In all cases, withdrawal reactions could be readily managed by gradually tapering the dose of the benzodiazepine.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment Research at the Crossroads: The Scientific Interface of Clinical Trials and Effectiveness Research
Wells
Am. J. Psychiatry 1999;156:5-10.
ABSTRACT | FULL TEXT  

Taking Policy Action to Reduce Benzodiazepine Use and Promote Self-Care Among Seniors
Hall
Journal of Applied Gerontology 1998;17:318-351.
ABSTRACT  

Addiction to Benzodiazepines--How Common?
Piper
Arch Fam Med 1995;4:964-970.
ABSTRACT  

Use of Benzodiazepines in Anxiety Disorders
Shader and Greenblatt
NEJM 1993;328:1398-1405.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.